A careful follow‐up of parents carrying heterozygous PARN mutation is therefore needed to anticipate potential development of pulmonary fibrosis, progressive bone marrow failure, or other ailments associated with premature aging. The gene discussed is PARN; the disease is pulmonary fibrosis.